PTAB Rules Against Apple In Masimo Blood Oximetry IP Fight


By Adam Lidgett (January 30, 2023, 6:43 PM EST) — The Patent Trial and Appeal Board on Monday dismissed Apple’s challenges to a patent on technology for measuring oxygen in blood owned by medical technology company Masimo Corp., just a couple of weeks after a U.S. International Trade Commission judge said Apple infringed that same patent….

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS



Source link

Previous articleApple Violated U.S. Labor Laws With Anti-Leak Email
Next articleMorgan Creek’s Mark Yusko Says Things Close to Getting Fun for Bitcoin (BTC) – Here’s His Outlook